Literature DB >> 18830387

Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2).

Lorinda Marie Wright1, Sheri Yong, Maria Mrozowicz Picken, Don Rockey, Claus Jüergen Fimmel.   

Abstract

GP73 (Golph2) is a type II Golgi-localized integral membrane protein that is normally expressed in epithelial cells of many human tissues, and that is highly upregulated in liver disease. While its function is unknown, the GP73 C-terminus contains putative protein-interaction domains. We used a gene trap approach to generate mice with a severe truncation of the GP73 C-terminus (GP73(tr/tr)) in order to investigate the physiological role of this protein. GP73(tr/tr) mice were born at the expected rate and were fertile, but cumulative survival was significantly reduced compared to wild-type controls, particularly in females. GP73(tr/tr) mice developed varying degrees of renal disease, most notably focal segmental glomerulosclerosis and hyaline thrombi. In addition to renal abnormalities, GP73(tr/tr) mice developed marked microvesicular hepatic steatosis, hepatocyte nuclear membrane irregularities and intranuclear inclusions. GP73(tr/tr) expression in morphologically normal kidneys and livers was constitutively low, but was strikingly upregulated in the diseased kidney cortex, and was upregulated in livers in animals of advanced age. Despite the substantial morphological changes in the kidneys and liver, routine screening serum assays provided no evidence of renal or hepatic dysfunction. Consequently, the cause of the increased mortality of GP73(tr/tr) animals is unclear at present. Our study indicates that GP73 is essential for normal survival, and suggests multiple roles for GP73 in epithelial cell function in the kidney and liver.

Entities:  

Keywords:  GP73 (Golph2); Golgi membrane protein; epithelial cells; glomerulosclerosis; hepatic steatosis; hyaline thrombi

Year:  2008        PMID: 18830387      PMCID: PMC2491393     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption.

Authors:  Sapna Puri; Collin Bachert; Claus J Fimmel; Adam D Linstedt
Journal:  Traffic       Date:  2002-09       Impact factor: 6.215

2.  Microwave-stimulated formaldehyde fixation of experimental renal biopsy tissues: computerised morphometric analysis of distortion artefacts.

Authors:  Lai-Meng Looi; Kum-Chee Loh
Journal:  Malays J Pathol       Date:  2005-06       Impact factor: 0.656

3.  Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.

Authors:  Chaim O Jacob; Luminita Pricop; Chaim Putterman; Michael N Koss; Yi Liu; Maria Kollaros; Sarah A Bixler; Christine M Ambrose; Martin L Scott; William Stohl
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

Review 4.  Newer markers for hepatocellular carcinoma.

Authors:  Jorge A Marrero; Anna S F Lok
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.

Authors:  Raleigh D Kladney; Xiaoyen Cui; Gary A Bulla; Elizabeth M Brunt; Claus J Fimmel
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

6.  Large granular lymphoproliferative disease associated with nephrotic syndrome, renal failure and leukoencephalopathy.

Authors:  R Chen; J H Matthews; A C Jackson
Journal:  Leuk Lymphoma       Date:  1993-09

7.  Diagnosis of hepatocellular carcinoma by fine needle aspiration cytology. Cellular features.

Authors:  Işin Soyuer; Cemil Ekinci; Muhsin Kaya; Yasemin Genç; Kadir Bahar
Journal:  Acta Cytol       Date:  2003 Jul-Aug       Impact factor: 2.319

8.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.

Authors:  Doug Stryke; Michiko Kawamoto; Conrad C Huang; Susan J Johns; Leslie A King; Courtney A Harper; Elaine C Meng; Roy E Lee; Alice Yee; Larry L'Italien; Pao-Tien Chuang; Stephen G Young; William C Skarnes; Patricia C Babbitt; Thomas E Ferrin
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

9.  The International Gene Trap Consortium Website: a portal to all publicly available gene trap cell lines in mouse.

Authors:  Alex S Nord; Patricia J Chang; Bruce R Conklin; Antony V Cox; Courtney A Harper; Geoffrey G Hicks; Conrad C Huang; Susan J Johns; Michiko Kawamoto; Songyan Liu; Elaine C Meng; John H Morris; Janet Rossant; Patricia Ruiz; William C Skarnes; Philippe Soriano; William L Stanford; Doug Stryke; Harald von Melchner; Wolfgang Wurst; Ken-ichi Yamamura; Stephen G Young; Patricia C Babbitt; Thomas E Ferrin
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  The need to decide if all estrogens are intrinsically similar.

Authors:  Jonathan G Moggs; John Ashby; Helen Tinwell; Fei Ling Lim; David J Moore; Ian Kimber; George Orphanides
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

View more
  30 in total

1.  Hepatocyte GP73 expression in Wilson disease.

Authors:  Lorinda M Wright; Dominik Huster; Svetlana Lutsenko; Fritz Wrba; Peter Ferenci; Claus J Fimmel
Journal:  J Hepatol       Date:  2009-06-25       Impact factor: 25.083

2.  Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.

Authors:  Hongyan Liang; Timothy M Block; Mengjun Wang; Bradley Nefsky; Ronald Long; Julie Hafner; Anand S Mehta; Jorge Marrero; Robert Gish; Pamela A Norton
Journal:  Cancer Biomark       Date:  2012       Impact factor: 4.388

3.  Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin.

Authors:  Yan Zhou; Leike Li; Longbo Hu; Tao Peng
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

4.  Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.

Authors:  Sooryanarayana Varambally; Bharathi Laxman; Rohit Mehra; Qi Cao; Saravana M Dhanasekaran; Scott A Tomlins; Jill Granger; Adaikkalam Vellaichamy; Arun Sreekumar; Jianjun Yu; Wenjuan Gu; Ronglai Shen; Debashis Ghosh; Lorinda M Wright; Raleigh D Kladney; Rainer Kuefer; Mark A Rubin; Claus J Fimmel; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

5.  GOLPH2 expression may serve as diagnostic marker in seminomas.

Authors:  Florian R Fritzsche; Glen Kristiansen; Marc-Oliver Riener; Manfred Dietel; Beibei Oelrich
Journal:  BMC Urol       Date:  2010-02-25       Impact factor: 2.264

6.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

7.  GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population.

Authors:  Jin-song Hu; De-wu Wu; Shuo Liang; Xiong-yin Miao
Journal:  Med Oncol       Date:  2009-04-28       Impact factor: 3.064

8.  GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy.

Authors:  Hongshan Wei; Xiaohua Hao; Boan Li; Xingwang Li; Jun Hou; Yong Qiao; Renwen Zhang; Xin Li
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

Review 9.  GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.

Authors:  Ming-Chen Ba; Hui Long; Yun-Qiang Tang; Shu-Zhong Cui
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

10.  Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.

Authors:  Hongshan Wei; Boan Li; Renwen Zhang; Xiaohua Hao; Yubo Huang; Yong Qiao; Jun Hou; Xin Li; Xingwang Li
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.